Butuanimides, Fatty Acid Synthesis-Inhibiting Antibiotics from Symbiotic Bacteria
ACS Chemical Biology · 15.05.2026 · 21 (5) · 1125-1134
DOI: 10.1021/acschembio.6c00130 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 28.04.2026. Verfasst von Bailey W Miller und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah 84112, United States. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Fatty Acid Synthesis Inhibitors, Fatty Acids. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, FIC NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
High Resolution Image Download MS PowerPoint Slide With the ongoing antibiotic drug resistance crisis, new molecules with new mechanisms of action are essential. Here, we characterized quorum sensing-regulated butuanimides from symbiotic γ-proteobacteria, Teredinibacter sp. 2052S, which kill Gram-positive bacterial and human cells with micromolar and submicromolar potencies, respectively. Butuanimides share a peptide-imide moiety with andrimid-class antibiotics that target bacterial acetyl-CoA carboxylase (ACC), the rate-limiting step in fatty acid biosynthesis. Similarly, site-directed mutagenesis in Acinetobacter baylyi identified the ACC carboxyl transferase (CT) subunit as responsible for butuanimide antibacterial activity. The andrimid-like peptide-imide moiety is attached to a longer, halogenated polyene chain that initiates with an unusual starter unit likely derived from phenylalanine. The resulting epoxyquinone is unstable in solution over a period of hours to days, enabling redox control of antibiotic action. Comparison of the hybrid polyketide synthase-nonribosomal peptide synthetase (PKS-NRPS) biosynthetic gene clusters of butuanimides and andrimid suggests the repurposing of a key phenylalanine-derived motif. The butuanimide structures link the thailandamide- and andrimid-class ACC inhibitors, which should aid ongoing efforts in the development of ACC inhibitors to treat multidrug-resistant infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah 84112, United States.
- Department of Genome Sciences, University of Washington, Seattle, Washington 98195, United States.
- The Marine Science Institute, University of the Philippines, Diliman, Quezon City 1101, Philippines.
ORCID-Profile: Bailey W Miller, Albebson L Lim, Mark Jeremiah B Cleofas, Jared T Seale, Jose Miguel D Robes, Margo G Haygood, Eric W Schmidt, Gisela P Concepcion
Förderung
- NIAID NIH HHS
- FIC NIH HHS
- NIGMS NIH HHS
- Fogarty International Center
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Miller, B. W., Lim, A. L., Bailey, J., Cleofas, M. J. B., Lacerna, N., Altamia, M. A., Seale, J. T., Robes, J. M. D., Naka, H., Manoil, C., Haygood, M. G., Schmidt, E. W., & Concepcion, G. P. (2026). Butuanimides, Fatty Acid Synthesis-Inhibiting Antibiotics from Symbiotic Bacteria. ACS Chemical Biology, 21(5), 1125-1134. https://doi.org/10.1021/acschembio.6c00130
Vancouver
Miller BW, Lim AL, Bailey J, Cleofas MJB, Lacerna N, Altamia MA, et al. Butuanimides, Fatty Acid Synthesis-Inhibiting Antibiotics from Symbiotic Bacteria. ACS Chemical Biology. 2026;21(5):1125-1134. doi:10.1021/acschembio.6c00130
BibTeX
@article{Miller2026,
author = {Miller, Bailey W and Lim, Albebson L and Bailey, Jeannie and Cleofas, Mark Jeremiah B and Lacerna, Noel and Altamia, Marvin A and Seale, Jared T and Robes, Jose Miguel D and Naka, Hiroaki and Manoil, Colin and Haygood, Margo G and Schmidt, Eric W and Concepcion, Gisela P},
title = {Butuanimides, Fatty Acid Synthesis-Inhibiting Antibiotics from Symbiotic Bacteria},
journal = {ACS Chemical Biology},
year = {2026},
volume = {21},
number = {5},
pages = {1125--1134},
doi = {10.1021/acschembio.6c00130}
}
EUVIMED